期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 較慢,6-12周

The Medical Letter, Inc. is committed to providing objective, practical, and timely information on drugs and treatments of common diseases to help our readers make the best decisions for their patients—without the influence of the pharmaceutical industry.

The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides:

Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts

New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings

Consensus recommendations for the preferred and alternative treatments for common disorders

Comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost.

《醫(yī)學(xué)快報(bào)》致力于提供客觀、實(shí)用、及時(shí)的常見(jiàn)疾病藥物和治療信息，幫助我們的讀者為患者做出最佳決策，不受制藥行業(yè)的影響。

《醫(yī)學(xué)快報(bào)：藥物和治療學(xué)》是一份雙周刊，提供：

基于證據(jù)、同行評(píng)審的 FDA 批準(zhǔn)新藥評(píng)估，結(jié)論由專家達(dá)成共識(shí)

有關(guān)先前批準(zhǔn)藥物的新信息，包括關(guān)鍵臨床試驗(yàn)、新適應(yīng)癥和安全警告

常見(jiàn)疾病首選和替代治療的共識(shí)建議

針對(duì)特定適應(yīng)癥的藥物進(jìn)行比較性評(píng)價(jià)，特別關(guān)注臨床療效、不良反應(yīng)、藥物相互作用和成本。

《Medical Letter On Drugs And Therapeutics》(關(guān)于藥物和治療學(xué)的醫(yī)學(xué)信函)編輯部通訊方式為MED LETTER INC, 1000 MAIN STREET, NEW ROCHELLE, USA, NY, 10801。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。